🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 10 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
31/05/2017 12,45 12,45 10,76 11,17 -5,50% 13,57% 357.000
30/05/2017 12,28 14,85 11,12 11,82 +43,80% 30,37% 3.234.700
26/05/2017 8,40 8,55 8,02 8,22 -4,31% 6,31% 32.300
25/05/2017 9,18 9,90 8,00 8,59 -5,60% 20,64% 43.800
24/05/2017 9,90 10,56 9,01 9,10 -7,71% 15,66% 30.700
23/05/2017 10,22 10,34 9,45 9,86 -5,56% 8,71% 40.900
22/05/2017 10,75 10,99 10,27 10,44 -1,42% 6,69% 7.600
19/05/2017 9,83 10,76 9,34 10,59 +7,40% 14,45% 14.900
18/05/2017 9,53 10,17 9,52 9,86 -4,27% 6,87% 9.200
17/05/2017 10,47 10,75 9,25 10,30 -3,83% 14,33% 38.500
16/05/2017 10,13 10,75 10,13 10,71 -0,28% 6,12% 12.100
15/05/2017 10,62 10,77 10,09 10,74 +2,78% 6,36% 12.600
12/05/2017 10,62 10,75 10,00 10,45 +0,58% 7,06% 8.200
11/05/2017 9,98 10,90 9,72 10,39 +7,67% 11,84% 8.000
10/05/2017 10,20 10,20 9,01 9,65 +2,66% 11,67% 14.000
09/05/2017 9,19 9,50 9,01 9,40 +2,73% 5,33% 19.800
08/05/2017 9,59 9,97 9,05 9,15 -0,97% 9,59% 10.300
05/05/2017 10,38 10,40 9,24 9,24 -9,14% 11,18% 15.900
04/05/2017 10,21 10,27 10,12 10,17 -0,59% 1,47% 3.100
03/05/2017 10,37 10,53 10,07 10,23 -2,29% 4,44% 8.900
02/05/2017 10,54 10,76 10,34 10,47 -0,76% 3,95% 7.600
01/05/2017 10,50 10,67 10,11 10,55 +4,25% 5,33% 5.300
28/04/2017 10,50 10,51 10,06 10,12 -4,80% 4,29% 7.000
27/04/2017 10,92 11,13 10,44 10,63 +0,28% 6,32% 15.600
26/04/2017 10,66 10,75 10,44 10,60 +0,09% 2,91% 10.700
25/04/2017 10,29 10,72 10,04 10,59 +4,75% 6,61% 8.500
24/04/2017 10,77 10,77 10,00 10,11 -4,35% 7,15% 14.300
21/04/2017 10,81 10,94 10,48 10,57 -0,19% 4,21% 17.200
20/04/2017 11,11 11,11 10,51 10,59 +0,57% 5,40% 18.500
19/04/2017 10,58 10,78 10,23 10,53 -0,94% 5,20% 16.300